Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Заявленная компания
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions читать еще
A very good place to experience a lot and move at a fast pace; however, often frustrating due to lack of focus on main objectives for the company.
Чем вы больше всего довольны в вашем пакете компенсаций?
It is competitive with industry standards
Что вам больше всего нравится в команде руководства?
Open minded to alternative approaches and collaborative across functions
Что самое позитивное вы можете сказать о культуре и обстановке на вашей работе?
Coworkers are friendly and talented
Каковы самые лучшие качества в вашей команде?
Very collaborative and talented group
Что идёт не так, и как это можно улучшить?
Inconsistent goals and constantly shifting priorities by the day. Management rushes too much to push multiple objectives forward which results in work that often must be repeated or adjusted. More focus is needed to focus on a clear set of objectives.
Other Employee Reviews for Karyopharm Therapeutics
×